CDC Approves Novavax’s COVID Shot for Teens

Published on August 22, 2022

The U.S. Centers for Disease Control and Prevention (CDC) has given the green light for adolescents aged 12 through 17 to receive the COVID-19 vaccine developed by Novavax Inc. This is a big win in the fight against the pandemic, as more young people can now have an extra layer of protection. It’s like adding a new weapon to our arsenal! Just like how superheroes equip themselves with different gadgets to defeat the villain, having a variety of vaccines available is crucial in battling the virus. With the CDC’s recommendation, parents and guardians can feel more confident in getting their teens vaccinated. This is especially important as schools reopen and students come together in close quarters. It’s like giving them a shield to defend against illness! To learn more about the research behind Novavax’s COVID-19 vaccine and its effectiveness among adolescents, check out the full article.

The U.S. Centers for Disease Control and Prevention (CDC) on Monday signed off on the use of Novavax Inc’s COVID-19 vaccine for adolescents aged 12 through 17.

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>